Post-COVID boardroom shifts and policy tailwinds are catalysing a once-in-a-generation opportunity, Khemani says ...

With a lack of real breakthroughs since the 1960s, older methods such as electrical-based therapies are experiencing a revival in psychiatry.

Decoy Therapeutics, Inc. (Decoy), a privately held preclinical biopharmaceutical company engineering the next generation of peptide conjugate therapeutics, announces that Massachusetts Institute of ...

Jumio, the leading provider of automated, AI-driven biometric identity verification, risk signals and compliance solutions, today announced general availability of Cross-Transaction Risk, which helps ...

Millennium Pharma, and GSK. Narasimhan said Marshall is "an esteemed biomedical scientist and an accomplished biopharmaceuticals research leader" with "three decades of experience leading drug ...

The ownership group of Millennium Play, LLC and 612 Howard Street, a six-story, commercial office building located in the historic South-of-Market district of San Francisco, are excited to announce ...

NHS Hospital IT Leaders Cite Delayed Procurement, Interoperability Concerns, and Vendor Reevaluation as System Restructuring ...

Darren McConachie, 30, worried he was losing his hearing after suffering a terrible ear infection. Then, an object that had ...

Few companies embody the term 'pharma giant' as much as Pfizer ... The era of mega-mergers Since the turn of the millennium, Pfizer has embarked on a series of mega-mergers, gobbling up Warner ...

Novo catches up, Amazon pauses data center deals, Tesla earnings imminent, and ...